$BHC
Bausch Health Companies Inc. Stock $bhc

$bhc Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-K Financial Statement

#000088559016000101 Filed on April 29, 2016

Income Statement

Concept	2015 Q4	2014 Q4	2014 Q3
Revenue	$2.758B	$2.235B	$2.043B
YoY Change	23.38%	8.31%	32.54%
Cost Of Revenue	$676.7M	$571.3M	$545.8M
YoY Change	18.45%	-21.94%	-2.67%
Gross Profit	$2.060B	$1.651B	$1.498B
YoY Change	24.74%	23.97%	52.67%
Gross Profit Margin	74.68%	73.87%	73.29%
Selling, General & Admin	$742.9M	$524.5M	$504.1M
YoY Change	41.64%	16.48%	41.72%
% of Gross Profit	36.07%	31.76%	33.66%
Research & Development	$95.90M	$59.10M	$59.10M
YoY Change	62.27%	-0.67%	20.61%
% of Gross Profit	4.66%	3.58%	3.95%
Depreciation & Amortization	$698.6M	$365.9M	$439.3M
YoY Change	90.93%	-10.86%	-53.56%
% of Gross Profit	33.92%	22.16%	29.34%
Operating Expenses	$1.670B	$1.027B	$563.2M
YoY Change	62.57%	245.11%	39.16%
Operating Profit	$168.0M	$617.4M	$671.6M
YoY Change	-72.79%	-40.3%	-175.33%
Interest Expense	-$435.0M	-$18.10M	-$307.2M
YoY Change	2303.31%	-93.2%	27.26%
% of Operating Profit	-258.93%	-2.93%	-45.74%
Other Income/Expense, Net
YoY Change
Pretax Income	-$240.3M	$551.1M	$376.7M
YoY Change	-143.6%	-805.63%	-133.01%
Income Tax	$122.1M	$49.80M	$100.3M
% Of Pretax Income		9.04%	26.63%
Net Earnings	-$361.9M	$502.1M	$276.4M
YoY Change	-172.08%	305.57%	-128.44%
Net Earnings / Revenue	-13.12%	22.46%	13.53%
Basic Earnings Per Share	-$1.12	$1.53	$0.79
Diluted Earnings Per Share	-$1.12	$1.50	$0.78
COMMON SHARES
Basic Shares Outstanding	343.1M shares	335.7M shares	335.4M shares
Diluted Shares Outstanding			341.3M shares

Balance Sheet

Concept	2015 Q4	2014 Q4	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$597.0M	$323.0M	$809.0M
YoY Change	84.83%	-46.17%	35.74%
Cash & Equivalents	$597.0M	$323.0M	$808.8M
Short-Term Investments
Other Short-Term Assets	$966.0M	$844.0M	$792.0M
YoY Change	14.45%	16.25%	48.87%
Inventory	$1.257B	$889.2M	$932.7M
Prepaid Expenses
Receivables	$2.687B	$2.076B	$1.880B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.507B	$4.132B	$4.414B
YoY Change	33.29%	6.33%	14.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.442B	$1.312B	$1.300B
YoY Change	9.88%	6.33%	6.45%
Goodwill	$18.55B	$9.361B	$9.468B
YoY Change	98.19%	-4.01%	-2.81%
Intangibles	$23.08B	$11.28B	$11.62B
YoY Change	104.67%	-12.22%	-11.23%
Long-Term Investments
YoY Change
Other Assets	$224.0M	$167.4M	$233.4M
YoY Change	33.81%	-14.37%	-3.53%
Total Long-Term Assets	$43.46B	$22.17B	$22.65B
YoY Change	96.0%	-7.79%	-7.02%
TOTAL ASSETS
Total Short-Term Assets	$5.507B	$4.132B	$4.414B
Total Long-Term Assets	$43.46B	$22.17B	$22.65B
Total Assets	$48.97B	$26.30B	$27.06B
YoY Change	86.15%	-5.83%	-4.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$434.0M	$398.0M	$323.3M
YoY Change	9.05%	21.71%	-21.71%
Accrued Expenses	$3.859B	$2.157B	$1.994B
YoY Change	78.91%	19.82%	5.53%
Deferred Revenue
YoY Change
Short-Term Debt	$16.00M	$6.200M	$0.00
YoY Change	158.06%	-48.76%
Long-Term Debt Due	$823.0M	$900.0K	$690.6M
YoY Change	91344.44%	-99.56%	91.32%
Total Short-Term Liabilities	$5.313B	$2.708B	$3.143B
YoY Change	96.17%	7.8%	10.17%
LONG-TERM LIABILITIES
Long-Term Debt	$30.27B	$15.23B	$15.58B
YoY Change	98.75%	-11.27%	-8.56%
Other Long-Term Liabilities	$185.0M	$197.1M	$208.6M
YoY Change	-6.14%	22.8%	27.21%
Total Long-Term Liabilities	$30.45B	$15.43B	$15.79B
YoY Change	97.41%	-10.96%	-8.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.313B	$2.708B	$3.143B
Total Long-Term Liabilities	$30.45B	$15.43B	$15.79B
Total Liabilities	$42.94B	$20.90B	$21.83B
YoY Change	105.41%	-8.07%	-5.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.750B	-$2.398B	-$2.900B
YoY Change	14.69%	-26.86%	-14.77%
Common Stock	$10.20B	$8.593B	$8.575B
YoY Change	18.72%	0.74%	0.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.910B	$5.279B	$5.123B
YoY Change
Total Liabilities & Shareholders Equity	$48.97B	$26.30B	$27.06B
YoY Change	86.15%	-5.96%	-4.06%

Cashflow Statement

Concept	2015 Q4	2014 Q4	2014 Q3
OPERATING ACTIVITIES
Net Income	-$361.9M	$502.1M	$276.4M
YoY Change	-172.08%	305.57%	-128.44%
Depreciation, Depletion And Amortization	$698.6M	$365.9M	$439.3M
YoY Change	90.93%	-10.86%	-53.56%
Cash From Operating Activities	$598.0M	$815.7M	$618.7M
YoY Change	-26.69%	191.43%	206.74%
INVESTING ACTIVITIES
Capital Expenditures	-$81.20M	-$154.0M	$39.60M
YoY Change	-47.27%	61.93%	59.04%
Acquisitions			$606.8M
YoY Change			-86.33%
Other Investing Activities	-$1.454B	-$51.80M	$870.2M
YoY Change	2706.76%	4.65%	-119.6%
Cash From Investing Activities	-$1.535B	-$205.8M	$756.3M
YoY Change	645.92%	42.32%	-116.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net			$1.630B
YoY Change			-65.91%
Cash From Financing Activities	122.5M	-1.099B	-$1.082B
YoY Change	-111.15%	739.27%	-146.67%
NET CHANGE
Cash From Operating Activities	$598.0M	$815.7M	$618.7M
Cash From Investing Activities	-1.535B	-205.8M	$756.3M
Cash From Financing Activities	122.5M	-1.099B	-$1.082B
Net Change In Cash	$598.0M	$815.7M	$292.9M
YoY Change	-26.69%	18438.64%	-115.03%
FREE CASH FLOW
Cash From Operating Activities	$598.0M	$815.7M	$618.7M
Capital Expenditures	-$81.20M	-$154.0M	$39.60M
Free Cash Flow	$679.2M	$969.7M	$579.1M
YoY Change	-29.96%	158.59%	227.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0000885590
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	343019770	shares
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2015Q2	dei	Entity Public Float EntityPublicFloat	75445451000	USD
CY2015	dei	Entity Registrant Name EntityRegistrantName	Valeant Pharmaceuticals International, Inc.
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	398000000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	433700000	USD
CY2014Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2111700000	USD
CY2015Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2754200000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2075800000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2686900000	USD
CY2014Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	33300000	USD
CY2015Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	77300000	USD
CY2014Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	204900000	USD
CY2015Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	243500000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	122900000	USD
CY2015Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	221300000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2157000000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3859100000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	55600000	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	52800000	USD
CY2014Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	41400000	USD
CY2015Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	83800000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	977900000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1184000000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-119400000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-132800000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-915900000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1541600000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	243900000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	304900000	USD
CY2013	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-46600000	USD
CY2014	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-44100000	USD
CY2015	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-88000000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	45500000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78200000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	140100000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	24200000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	17100000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	56800000	USD
CY2013	us-gaap	Advertising Expense AdvertisingExpense	277000000	USD
CY2014	us-gaap	Advertising Expense AdvertisingExpense	435000000	USD
CY2015	us-gaap	Advertising Expense AdvertisingExpense	652000000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	46000000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	40000000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	95000000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35900000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	67300000	USD
CY2013	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	89500000	USD
CY2014	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	70000000	USD
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	145300000	USD
CY2013Q4	us-gaap	Assets Assets	27932900000	USD
CY2014Q4	us-gaap	Assets Assets	26304700000	USD
CY2015Q4	us-gaap	Assets Assets	48964500000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	4131700000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	5507200000	USD
CY2013	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-2.43
CY2014	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-1.09
CY2015	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-1.80
CY2013	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-2.43
CY2014	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-1.09
CY2015	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-1.80
CY2013	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-801900000	USD
CY2014	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-374700000	USD
CY2015	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-619100000	USD
CY2013	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	7929900000	USD
CY2014	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	10247600000	USD
CY2015	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	10709600000	USD
CY2013	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	36400000	USD
CY2014	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6300000	USD
CY2015	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	38500000	USD
CY2013	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	29200000	USD
CY2014	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	14100000	USD
CY2015	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	23000000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	515600000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	141800000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	196800000	USD
CY2015	us-gaap	Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed	43000000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	32400000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	6100000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	3100000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	3100000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	3400000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	4200000	USD
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	12500000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	916100000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	600300000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	322600000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	597300000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2015Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	334004879	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	334402964	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	342266409	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	342926531	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	334004879	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	334402964	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	342266409	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	342926531	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	8349200000	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	9897400000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-879500000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	97600000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-917400000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2800000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2900000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	100000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-876700000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	94700000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-917300000	USD
CY2015Q4	us-gaap	Contractual Obligation ContractualObligation	90000000	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1846300000	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2177700000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2531600000	USD
CY2013	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	58800000	USD
CY2014	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	58400000	USD
CY2015	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	53100000	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	6179100000	USD
CY2014Q1	us-gaap	Costs And Expenses CostsAndExpenses	1529600000	USD
CY2014Q2	us-gaap	Costs And Expenses CostsAndExpenses	1686000000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	3215600000	USD
CY2014Q3	us-gaap	Costs And Expenses CostsAndExpenses	1371700000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4587300000	USD
CY2014Q4	us-gaap	Costs And Expenses CostsAndExpenses	1618000000	USD
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	6205300000	USD
CY2015Q1	us-gaap	Costs And Expenses CostsAndExpenses	1599100000	USD
CY2015Q2	us-gaap	Costs And Expenses CostsAndExpenses	2390900000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	3990000000	USD
CY2015Q3	us-gaap	Costs And Expenses CostsAndExpenses	2339000000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	6329000000	USD
CY2015Q4	us-gaap	Costs And Expenses CostsAndExpenses	2590100000	USD
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	8919100000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3400000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	600000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2013	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	80000000	USD
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	150100000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	76900000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	83400000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	150700000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	76900000	USD
CY2015Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	31436600000	USD
CY2015Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.075
CY2015Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	348200000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3600000	USD
CY2013	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-534200000	USD
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	23500000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	59200000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-534200000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	23500000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	55600000	USD
CY2014Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3157200000	USD
CY2015Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7499900000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	13500000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	13100000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2031700000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3120100000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	193300000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1172500000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1753500000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	54000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	156000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	38200000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	234900000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	294800000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	49800000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	67900000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	369900000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	594200000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	859200000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1366600000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1984700000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	5746400000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	10700000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	0	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	520000000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4711400000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2221300000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	5902400000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	69600000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	18700000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	16600000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	2636600000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	2607000000	USD
CY2015	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Decrease On Accumulated Postretirement Benefit Obligation1 DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1	600000	USD
CY2015	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Increase On Accumulated Postretirement Benefit Obligation DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation	700000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	16000000	USD
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	21000000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	28000000	USD
CY2013	us-gaap	Depreciation Depreciation	114000000	USD
CY2014	us-gaap	Depreciation Depreciation	187000000	USD
CY2015	us-gaap	Depreciation Depreciation	209000000	USD
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2015800000	USD
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1737600000	USD
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2627500000	USD
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.53
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.63
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.70
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.85
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.70
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.08
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.50
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.58
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.85
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-5200000	USD
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-29000000	USD
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-30100000	USD
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2013	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	24200000	USD
CY2014	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	17100000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	56800000	USD
CY2014	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	398000000	USD
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	24200000	USD
CY2014	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	17100000	USD
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	56800000	USD
CY2015Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	14100000	USD
CY2015	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	23000000	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	4100000	USD
CY2015	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	1100000	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	132600000	USD
CY2015	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	1010400000	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	116800000	USD
CY2015	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	174000000	USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	355800000	USD
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	347600000	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1155900000	USD
CY2015	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P8Y
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5140600000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2176600000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2383900000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7411600000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2733200000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2522700000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2659000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14430900000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	28186700000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9290300000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20775100000	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-9400000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-144100000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-102800000	USD
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-9800000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-135100000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-95200000	USD
CY2013	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-353600000	USD
CY2014	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	283400000	USD
CY2015	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-41800000	USD
CY2013	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-10200000	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	253500000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-5400000	USD
CY2013	us-gaap	Gain Loss On Investments GainLossOnInvestments	5800000	USD
CY2014	us-gaap	Gain Loss On Investments GainLossOnInvestments	292600000	USD
CY2015	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2013	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-220500000	USD
CY2014	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	44700000	USD
CY2015	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-37300000	USD
CY2013	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-65000000	USD
CY2014Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-94000000	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-129600000	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20000000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	9752100000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	9361400000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	18552800000	USD
CY2014	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	411300000	USD
CY2015	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	9462700000	USD
CY2014	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-23900000	USD
CY2015	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	37200000	USD
CY2014	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-349200000	USD
CY2015	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-308500000	USD
CY2014	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	428900000	USD
CY2015Q4	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	79000000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-574500000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-851100000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1516000000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-739900000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1904700000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-155300000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1360700000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1314400000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1053600000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-450800000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	174200000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	132500000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	143900000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	255200000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	229400000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	6600000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	29600000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2013	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	3000000	USD
CY2014	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	32300000	USD
CY2015	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	87100000	USD
CY2013	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-407600000	USD
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-502800000	USD
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-350000000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	13100000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	19800000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	4400000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	24800000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	4100000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2100000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	0	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	50100000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	0	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	65100000	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	98700000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	94600000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-76500000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	246100000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	170300000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	300600000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	572400000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	625900000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	122700000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	192800000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	276000000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-121500000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	110300000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	90600000	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	5200000	USD
CY2013	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2014	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6100000	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2014Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	16418500000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3173000000	USD
CY2015Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	30494600000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11277900000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23083000000	USD
CY2013	us-gaap	Interest And Debt Expense InterestAndDebtExpense	844300000	USD
CY2014	us-gaap	Interest And Debt Expense InterestAndDebtExpense	971000000	USD
CY2015	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1563200000	USD
CY2013	us-gaap	Interest Paid InterestPaid	652900000	USD
CY2014	us-gaap	Interest Paid InterestPaid	934000000	USD
CY2015	us-gaap	Interest Paid InterestPaid	1269400000	USD
CY2014Q4	us-gaap	Interest Payable Current InterestPayableCurrent	196700000	USD
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	327800000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	603900000	USD
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	814600000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	889200000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	1256600000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	191100000	USD
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	289300000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	94200000	USD
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	152700000	USD
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	8000000	USD
CY2014	us-gaap	Investment Income Interest InvestmentIncomeInterest	5000000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	3300000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	20903000000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	42934700000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26304700000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48964500000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2708400000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5312600000	USD
CY2014Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	6800000	USD
CY2015Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	6700000	USD
CY2014Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	102600000	USD
CY2015Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	120200000	USD
CY2014Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	8000000	USD
CY2015Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	12300000	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	15228900000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	31088400000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	900000	USD
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	823000000	USD
CY2014Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	15780000000	USD
CY2015Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	29600000000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	16777500000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	823000000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	7829300000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2202900000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	630900000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15228000000	USD
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	30265400000	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	122300000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	118800000	USD
CY2013	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2100000	USD
CY2014	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2200000	USD
CY2015	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	8500000	USD
CY2014	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	3300000	USD
CY2013	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-315800000	USD
CY2014	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-277700000	USD
CY2015	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	274700000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4027700000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2443700000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13681800000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5380300000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-99700000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15577400000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1042000000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	484300000	USD
CY2014Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	376000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	860300000	USD
CY2014Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	618700000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1479000000	USD
CY2014Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	815700000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2294700000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	491100000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	410500000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	901600000	USD
CY2015Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	736500000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1638100000	USD
CY2015Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	562300000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2200400000	USD
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2500000	USD
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1300000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3900000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-866100000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22600000	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	125800000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	103200000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	265000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	368200000	USD
CY2014Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	512500000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	880700000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	97700000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-53000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	44700000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	49500000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	94200000	USD
CY2015Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-385900000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-291700000	USD
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	4264700000	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	11200000	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	3129200000	USD
CY2013	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	113900000	USD
CY2014	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	15000000	USD
CY2015	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	4900000	USD
CY2013Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1234200000	USD
CY2014Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1312300000	USD
CY2015Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1441800000	USD
CY2015Q4	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	100	country
CY2015	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2015	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-409500000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	356600000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	355100000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	711700000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	671600000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1383300000	USD
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	617400000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	2000700000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	571000000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	341500000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	912500000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	447800000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1360300000	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	167100000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	1527400000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	383000000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	79400000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	33800000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	41500000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	48500000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	57900000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	121900000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	52000000	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	75000000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	85000000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	210800000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	278100000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	167400000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	223700000	USD
CY2013	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-27900000	USD
CY2014	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-29400000	USD
CY2015	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-37800000	USD
CY2014	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	66900000	USD
CY2015	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-17200000	USD
CY2013	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	24500000	USD
CY2014	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-127300000	USD
CY2015	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	20800000	USD
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-50500000	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-717800000	USD
CY2015	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-646700000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	0	USD
CY2014	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-2500000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-3100000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-50900000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-717800000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-646700000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-50800000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-716200000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-642900000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-200000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-5200000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	600000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-13100000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-784700000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-629500000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-13100000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-784700000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-629500000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-37800000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	66900000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-17200000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	4000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	1800000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	15400000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-27400000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	2600000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	197100000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	184600000	USD
CY2013	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3800000	USD
CY2014	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-32300000	USD
CY2015	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	11200000	USD
CY2013	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-287200000	USD
CY2014	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	268700000	USD
CY2015	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-256100000	USD
CY2013	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	0	USD
CY2014	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	0	USD
CY2015	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	26300000	USD
CY2013	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	180800000	USD
CY2014	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	3200000	USD
CY2015	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	32900000	USD
CY2013	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	130100000	USD
CY2014	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	106100000	USD
CY2015	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	150900000	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	55600000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	72400000	USD
CY2013	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	72100000	USD
CY2014	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	52200000	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	102900000	USD
CY2013Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	31000000	USD
CY2015Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	18000000	USD
CY2013	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	65500000	USD
CY2014	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	44100000	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	88000000	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5253500000	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1102600000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15457400000	USD
CY2013	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2014	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	75900000	USD
CY2015	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	69600000	USD
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	179000000	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	68100000	USD
CY2013	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	18200000	USD
CY2014	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	72000000	USD
CY2015	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	49300000	USD
CY2013	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	115300000	USD
CY2014	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	291600000	USD
CY2015	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	235200000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	115300000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	291600000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	235200000	USD
CY2013	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2100000	USD
CY2014	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	8200000	USD
CY2015	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	8300000	USD
CY2014Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	239800000	USD
CY2015Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	190400000	USD
CY2014Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	8000000	USD
CY2015Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	20000000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	650800000	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	966400000	USD
CY2013	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	0	USD
CY2014	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	0	USD
CY2015	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	184600000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2307400000	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1432800000	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	8385400000	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1629600000	USD
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	17817400000	USD
CY2013	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	USD
CY2014	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	USD
CY2015	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-3122800000	USD
CY2013	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	35200000	USD
CY2014	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	53200000	USD
CY2015	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	66700000	USD
CY2013	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2014	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	76000000	USD
CY2014	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	75900000	USD
CY2015	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	41100000	USD
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1492300000	USD
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	12800000	USD
CY2013	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	27400000	USD
CY2014	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	19400000	USD
CY2015	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	7600000	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10000000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	17200000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	30200000	USD
CY2013	us-gaap	Profit Loss ProfitLoss	-863600000	USD
CY2014	us-gaap	Profit Loss ProfitLoss	879400000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	-287800000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2290200000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2625800000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1312300000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1441800000	USD
CY2015Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	27000000	USD
CY2014Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	2075800000	USD
CY2015Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	2686900000	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6326200000	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3888000000	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2055100000	USD
CY2013	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	75100000	USD
CY2014	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	28400000	USD
CY2015	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	7900000	USD
CY2013	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	156800000	USD
CY2014	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	246000000	USD
CY2015	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	334400000	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	361900000	USD
CY2014Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	66600000	USD
CY2013	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	151900000	USD
CY2014	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	21000000	USD
CY2015	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	144500000	USD
CY2013	us-gaap	Restructuring Charges RestructuringCharges	462000000	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	381700000	USD
CY2015Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	60700000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	10800000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2397800000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2749700000	USD
CY2013	us-gaap	Revenues Revenues	5769600000	USD
CY2014Q1	us-gaap	Revenues Revenues	1886200000	USD
CY2014Q2	us-gaap	Revenues Revenues	2041100000	USD
	us-gaap	Revenues Revenues	3927300000	USD
CY2014Q3	us-gaap	Revenues Revenues	2043300000	USD
	us-gaap	Revenues Revenues	5970600000	USD
CY2014Q4	us-gaap	Revenues Revenues	2235400000	USD
CY2014	us-gaap	Revenues Revenues	8206000000	USD
CY2015Q1	us-gaap	Revenues Revenues	2170100000	USD
CY2015Q2	us-gaap	Revenues Revenues	2732400000	USD
	us-gaap	Revenues Revenues	4902500000	USD
CY2015Q3	us-gaap	Revenues Revenues	2786800000	USD
	us-gaap	Revenues Revenues	7689300000	USD
CY2015Q4	us-gaap	Revenues Revenues	2757200000	USD
CY2015	us-gaap	Revenues Revenues	10446500000	USD
CY2013	us-gaap	Royalty Revenue RoyaltyRevenue	129300000	USD
CY2014	us-gaap	Royalty Revenue RoyaltyRevenue	159900000	USD
CY2015	us-gaap	Royalty Revenue RoyaltyRevenue	154300000	USD
CY2014Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	24700000	USD
CY2015Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	37100000	USD
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5640300000	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	8046100000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	10292200000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1305200000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2026300000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2699800000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	45500000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	78200000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	140100000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2014Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	6200000	USD
CY2015Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	15500000	USD
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	27058824	shares
CY2015Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	7286432	shares
CY2013Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2300000000	USD
CY2015Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1450000000	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2306900000	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1482300000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6400000	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16100000	USD
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	30200000	USD
CY2013	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	55600000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	50200000	USD
CY2015	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	72400000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	5279400000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	5911000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	39300000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3717400000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5233300000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5401700000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	39000000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6029800000	USD
CY2015Q4	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	23000000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	128000000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	247500000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	345000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	344000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	60700000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	143000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	46000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	8000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	7000000	USD
CY2014	vrx	Business Combination Contingent Consideration Arrangements Fair Value Adjustment BusinessCombinationContingentConsiderationArrangementsFairValueAdjustment	19000000	USD
CY2014Q4	vrx	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	205800000	USD
CY2015Q4	vrx	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	959100000	USD
CY2014Q3	vrx	Collaborative Agreement Milestone Payment Period CollaborativeAgreementMilestonePaymentPeriod	P5Y
CY2015Q4	vrx	Collaborative Agreement Milestone Payments Aggregate CollaborativeAgreementMilestonePaymentsAggregate	1500000000	USD
CY2014Q4	vrx	Collaborative Agreement Milestone Payments Due CollaborativeAgreementMilestonePaymentsDue	62000000	USD
CY2015Q4	vrx	Collaborative Agreement Milestone Payments Due CollaborativeAgreementMilestonePaymentsDue	49000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4600000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	19400000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	12800000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	23300000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	8100000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	5000000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	109000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	127000000	USD
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	382000000	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	507000000	USD
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	321000000	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	341500000	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	342700000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	321000000	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335400000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	342700000	shares
CY2014Q4	vrx	Accrued Capital Expenditures Current AccruedCapitalExpendituresCurrent	25600000	USD
CY2015Q4	vrx	Accrued Capital Expenditures Current AccruedCapitalExpendituresCurrent	17400000	USD
CY2014Q4	vrx	Accrued Product Rebate Current AccruedProductRebateCurrent	692500000	USD
CY2015Q4	vrx	Accrued Product Rebate Current AccruedProductRebateCurrent	901900000	USD
CY2014Q4	vrx	Accrued Product Return Current AccruedProductReturnCurrent	380300000	USD
CY2015Q4	vrx	Accrued Product Return Current AccruedProductReturnCurrent	626400000	USD
CY2015Q4	vrx	Accumulated Losses Preacquisition Non Qualified Stock Options And Restricted Stock Awards AccumulatedLossesPreacquisitionNonQualifiedStockOptionsAndRestrictedStockAwards	86000000	USD
CY2013	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	372400000	USD
CY2014	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	27300000	USD
CY2015	vrx	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	133700000	USD
CY2015Q2	vrx	Allocated Sharebase Compensation Expense Reversal AllocatedSharebaseCompensationExpenseReversal	6000000	USD
CY2015	vrx	Allocated Sharebased Compensation Expense Relatedto Modified Awards AllocatedSharebasedCompensationExpenseRelatedtoModifiedAwards	12000000	USD
CY2013	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	68300000	USD
CY2014	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	81300000	USD
CY2015	vrx	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	115300000	USD
CY2013	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1902000000	USD
CY2014	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1550700000	USD
CY2015	vrx	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	2418300000	USD
CY2013	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	76100000	USD
CY2014	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	132600000	USD
CY2015	vrx	Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue	1695800000	USD
CY2013	vrx	Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold	370000000	USD
CY2014	vrx	Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold	20000000	USD
CY2015	vrx	Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold	130000000	USD
CY2013	vrx	Business Acquisition Pro Forma Acquisition Related Costs BusinessAcquisitionProFormaAcquisitionRelatedCosts	25000000	USD
CY2014	vrx	Business Acquisition Pro Forma Acquisition Related Costs BusinessAcquisitionProFormaAcquisitionRelatedCosts	2000000	USD
CY2015	vrx	Business Acquisition Pro Forma Acquisition Related Costs BusinessAcquisitionProFormaAcquisitionRelatedCosts	35000000	USD
CY2013	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-29200000	USD
CY2014	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	75600000	USD
CY2015	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-7000000	USD
CY2014Q3	vrx	Collaborative Agreement Milestone Payments Due Potential CollaborativeAgreementMilestonePaymentsDuePotential	100000000	USD
CY2015	vrx	Concentration Risk Percentageof Net Trade Receivables ConcentrationRiskPercentageofNetTradeReceivables	0.40
CY2013Q2	vrx	Deferred Compensation Arrangementwith Individual Compensation Expense Increase Decrease Reclassificationof Award DeferredCompensationArrangementwithIndividualCompensationExpenseIncreaseDecreaseReclassificationofAward	21000000	USD
CY2014	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-14100000	USD
CY2013	vrx	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-515900000	USD
CY2015	vrx	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-23000000	USD
CY2014Q4	vrx	Deferred Tax Assets Deferred Expense Deferred Financing And Share Issue Costs DeferredTaxAssetsDeferredExpenseDeferredFinancingAndShareIssueCosts	209400000	USD
CY2015Q4	vrx	Deferred Tax Assets Deferred Expense Deferred Financing And Share Issue Costs DeferredTaxAssetsDeferredExpenseDeferredFinancingAndShareIssueCosts	525300000	USD
CY2014Q4	vrx	Deferred Tax Assets Plant Equipment And Technology DeferredTaxAssetsPlantEquipmentAndTechnology	2800000	USD
CY2015Q4	vrx	Deferred Tax Assets Plant Equipment And Technology DeferredTaxAssetsPlantEquipmentAndTechnology	0	USD
CY2014Q4	vrx	Deferred Tax Assets Scientific Research And Experimental Development Pool DeferredTaxAssetsScientificResearchAndExperimentalDevelopmentPool	58200000	USD
CY2015Q4	vrx	Deferred Tax Assets Scientific Research And Experimental Development Pool DeferredTaxAssetsScientificResearchAndExperimentalDevelopmentPool	50700000	USD
CY2014Q4	vrx	Deferred Tax Assets Tax Credit Carryforwards Research And Development DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment	90500000	USD
CY2015Q4	vrx	Deferred Tax Assets Tax Credit Carryforwards Research And Development DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment	134400000	USD
CY2014Q4	vrx	Deferred Tax Assets Tax Loss Carryforwards DeferredTaxAssetsTaxLossCarryforwards	964500000	USD
CY2015Q4	vrx	Deferred Tax Assets Tax Loss Carryforwards DeferredTaxAssetsTaxLossCarryforwards	1439700000	USD
CY2014Q4	vrx	Deferred Tax Liabilities Basis Difference Of Convertible Notes DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes	0	USD
CY2015Q4	vrx	Deferred Tax Liabilities Basis Difference Of Convertible Notes DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes	16200000	USD
CY2014Q4	vrx	Deferred Tax Liabilities Prepaid Expense DeferredTaxLiabilitiesPrepaidExpense	600000	USD
CY2015Q4	vrx	Deferred Tax Liabilities Prepaid Expense DeferredTaxLiabilitiesPrepaidExpense	95700000	USD
CY2015	vrx	Defined Benefit Plan Actuarial Gain Loss Amortization Threshold Percentage DefinedBenefitPlanActuarialGainLossAmortizationThresholdPercentage	0.1
CY2015	vrx	Defined Benefit Plan Employer Contribution Maximum Age DefinedBenefitPlanEmployerContributionMaximumAge	P65Y
CY2015	vrx	Defined Benefit Plan Estimated Future Benefit Payments Period DefinedBenefitPlanEstimatedFutureBenefitPaymentsPeriod	P10Y
CY2013	vrx	Effective Income Tax Rate Reconciliation Fees Paid Amount EffectiveIncomeTaxRateReconciliationFeesPaidAmount	0	USD
CY2014	vrx	Effective Income Tax Rate Reconciliation Fees Paid Amount EffectiveIncomeTaxRateReconciliationFeesPaidAmount	3500000	USD
CY2015	vrx	Effective Income Tax Rate Reconciliation Fees Paid Amount EffectiveIncomeTaxRateReconciliationFeesPaidAmount	15900000	USD
CY2015Q4	vrx	Estimated Unrecognized Tax Benefits Realized In Next Twelve Months EstimatedUnrecognizedTaxBenefitsRealizedInNextTwelveMonths	7000000	USD
CY2014	vrx	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Release From Restricted Cash FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReleaseFromRestrictedCash	5800000	USD
CY2015	vrx	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Release From Restricted Cash FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReleaseFromRestrictedCash	4000000	USD
CY2015	vrx	Highly Liquid Investments Maturity Period HighlyLiquidInvestmentsMaturityPeriod	P3M
CY2013	vrx	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	70200000	USD
CY2014	vrx	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	17400000	USD
CY2015	vrx	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	114000000	USD
CY2013	vrx	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	-5700000	USD
CY2014	vrx	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	-147300000	USD
CY2015	vrx	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	-374900000	USD
CY2013	vrx	Income Tax Reconciliation Foreign Currency Transaction Gain IncomeTaxReconciliationForeignCurrencyTransactionGain	600000	USD
CY2014	vrx	Income Tax Reconciliation Foreign Currency Transaction Gain IncomeTaxReconciliationForeignCurrencyTransactionGain	22800000	USD
CY2015	vrx	Income Tax Reconciliation Foreign Currency Transaction Gain IncomeTaxReconciliationForeignCurrencyTransactionGain	173600000	USD
CY2013	vrx	Income Tax Reconciliation Foreign Withholding Tax IncomeTaxReconciliationForeignWithholdingTax	3400000	USD
CY2014	vrx	Income Tax Reconciliation Foreign Withholding Tax IncomeTaxReconciliationForeignWithholdingTax	3700000	USD
CY2015	vrx	Income Tax Reconciliation Foreign Withholding Tax IncomeTaxReconciliationForeignWithholdingTax	6700000	USD
CY2013	vrx	Income Tax Reconciliation Nondeductible Expense Merger And Acquisition Costs IncomeTaxReconciliationNondeductibleExpenseMergerAndAcquisitionCosts	1100000	USD
CY2014	vrx	Income Tax Reconciliation Nondeductible Expense Merger And Acquisition Costs IncomeTaxReconciliationNondeductibleExpenseMergerAndAcquisitionCosts	0	USD
CY2015	vrx	Income Tax Reconciliation Nondeductible Expense Merger And Acquisition Costs IncomeTaxReconciliationNondeductibleExpenseMergerAndAcquisitionCosts	3100000	USD
CY2013	vrx	Income Tax Reconciliation Taxable Foreign Income IncomeTaxReconciliationTaxableForeignIncome	55400000	USD
CY2014	vrx	Income Tax Reconciliation Taxable Foreign Income IncomeTaxReconciliationTaxableForeignIncome	269000000	USD
CY2015	vrx	Income Tax Reconciliation Taxable Foreign Income IncomeTaxReconciliationTaxableForeignIncome	441400000	USD
CY2013	vrx	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	0	USD
CY2014	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	51300000	USD
CY2014	vrx	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	-1800000	USD
CY2015	vrx	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	-100000	USD
CY2015	vrx	Maximum Term Of Original Maturity To Classify Instruments As Cash And Cash Equivalents MaximumTermOfOriginalMaturityToClassifyInstrumentsAsCashAndCashEquivalents	P3M
CY2015	vrx	Minimum Period To Classify Uncertain Tax Position Liabilities As Long Term Liabilities MinimumPeriodToClassifyUncertainTaxPositionLiabilitiesAsLongTermLiabilities	P1Y
CY2013	vrx	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-600000	USD
CY2014	vrx	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-900000	USD
CY2015	vrx	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-2700000	USD
CY2013	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	0	USD
CY2015	vrx	Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax	0	USD
CY2013	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	4000000	USD
CY2014	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	1800000	USD
CY2015	vrx	Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax	0	USD
CY2013	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2014	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax	51300000	USD
CY2015	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Auction Rate Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnAuctionRateSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2013	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	3600000	USD
CY2014	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	1800000	USD
CY2015	vrx	Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2014	vrx	Past Due Period For Accounts Receivable To Be Negligible PastDuePeriodForAccountsReceivableToBeNegligible	P90D
CY2015	vrx	Past Due Period For Accounts Receivable To Be Negligible PastDuePeriodForAccountsReceivableToBeNegligible	P90D
CY2013	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	11100000	USD
CY2014	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	10700000	USD
CY2015	vrx	Payment Of Accreted Interest On Contingent Consideration PaymentOfAccretedInterestOnContingentConsideration	23000000	USD
CY2013	vrx	Paymentof Deferred Consideration PaymentofDeferredConsideration	0	USD
CY2014	vrx	Paymentof Deferred Consideration PaymentofDeferredConsideration	0	USD
CY2015	vrx	Paymentof Deferred Consideration PaymentofDeferredConsideration	54700000	USD
CY2015	vrx	Period Receivable Outstanding PeriodReceivableOutstanding	P90D
CY2013	vrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	327500000	shares
CY2015	vrx	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	348800000	shares
CY2013	vrx	Research And Development In Process And Other Charges ResearchAndDevelopmentInProcessAndOtherCharges	153600000	USD
CY2014	vrx	Research And Development In Process And Other Charges ResearchAndDevelopmentInProcessAndOtherCharges	41000000	USD
CY2015	vrx	Research And Development In Process And Other Charges ResearchAndDevelopmentInProcessAndOtherCharges	248400000	USD
CY2013	vrx	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	0	USD
CY2013Q2	vrx	Saleof Stock Public Offering Price Per Share SaleofStockPublicOfferingPricePerShare	85.00
CY2015Q1	vrx	Saleof Stock Public Offering Price Per Share SaleofStockPublicOfferingPricePerShare	199.00
CY2015Q1	vrx	Sharebased Compensation Arrangementby Sharebased Payment Award Additional Purchase Optionasa Percentageof Shares Issuedin Ipo Maximum SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalPurchaseOptionasaPercentageofSharesIssuedinIPOMaximum	0.15
CY2013Q2	vrx	Sharebased Compensation Expense Increase Decrease Reclassificationof Award SharebasedCompensationExpenseIncreaseDecreaseReclassificationofAward	-6000000	USD
CY2014	vrx	Stock Issued During Period Value Equity Settlement And Reclassification Of Call Options StockIssuedDuringPeriodValueEquitySettlementAndReclassificationOfCallOptions	-3100000	USD
CY2015	vrx	Stock Repurchase Program Number Of Shares Repurchased StockRepurchaseProgramNumberOfSharesRepurchased	0	shares
CY2013Q4	vrx	Stockholders Equity Before Comprehensive Income Net Of Tax StockholdersEquityBeforeComprehensiveIncomeNetOfTax	6110000000	USD
CY2014Q4	vrx	Stockholders Equity Before Comprehensive Income Net Of Tax StockholdersEquityBeforeComprehensiveIncomeNetOfTax	5307000000	USD
CY2015Q4	vrx	Stockholders Equity Before Comprehensive Income Net Of Tax StockholdersEquityBeforeComprehensiveIncomeNetOfTax	6947100000	USD
CY2015	vrx	Tax Benefit Recognition Measurement Percentage TaxBenefitRecognitionMeasurementPercentage	0.5
CY2014	vrx	Unrecognized Tax Benefits Decrease Resultingfrom Priorand Current Period Tax Positions UnrecognizedTaxBenefitsDecreaseResultingfromPriorandCurrentPeriodTaxPositions	46000000	USD
CY2015	vrx	Unrecognized Tax Benefits Decrease Resultingfrom Priorand Current Period Tax Positions UnrecognizedTaxBenefitsDecreaseResultingfromPriorandCurrentPeriodTaxPositions	21000000	USD
CY2014Q4	vrx	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	345000000	USD
CY2015Q4	vrx	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	344000000	USD
CY2014	vrx	Unrecognized Tax Benefits Increase Resultingfrom Priorand Current Period Tax Positions UnrecognizedTaxBenefitsIncreaseResultingfromPriorandCurrentPeriodTaxPositions	143000000	USD
CY2015	vrx	Unrecognized Tax Benefits Increase Resultingfrom Priorand Current Period Tax Positions UnrecognizedTaxBenefitsIncreaseResultingfromPriorandCurrentPeriodTaxPositions	5000000	USD
CY2015Q4	vrx	Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate	217000000	USD
CY2015	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform with the current year presentation. Such amounts include a reclassification of </font><font style="font-family:inherit;font-size:10pt;">$26 million</font><font style="font-family:inherit;font-size:10pt;"> of debt issuance costs as of December 31, 2014 from Other long-term assets, net to Long-term debt (treated as a deduction to Long-term debt) on the consolidated balance sheet as a result of adoption of guidance issued by the Financial Accounting Standards Board (“FASB”) (see below under “Adoption of New Accounting Standards” in this Note 3 for more details). </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The reclassifications described above had no effect on the Company’s previously reported results of operations</font></div></div>
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Credit Risk</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities and accounts receivable.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invests its excess cash in high-quality, money market instruments and term deposits with varying maturities, but typically less than </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">The Company maintains its cash and cash equivalents with major financial institutions. The Company has not experienced any significant losses on its cash or cash equivalents.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s accounts receivable primarily represent amounts due from wholesale distributors, retail pharmacies, government entities and group purchasing organizations. Outside of the U.S., concentrations of credit risk with respect to trade receivables, which are typically unsecured, are limited due to the number of customers using the Company’s products, as well as their dispersion across many different geographic areas. The Company performs periodic credit evaluations of customers and does not require collateral. The Company monitors economic conditions, including volatility associated with international economies, and related impacts on the relevant financial markets and its business, especially in light of sovereign credit issues. The credit and economic conditions within Italy, Portugal, Spain, Greece, among other members of the European Union, Russia, Brazil, and Egypt have been weak in recent years. These conditions have increased, and may continue to increase, the average length of time that it takes to collect on the Company’s accounts receivable outstanding in these countries. An allowance for doubtful accounts is maintained for potential credit losses based on the aging of accounts receivable, historical bad debts experience, and changes in customer payment patterns. Accounts receivable balances are written off against the allowance when it is deemed probable that the receivable will not be collected.</font></div></div>
CY2015	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valeant Pharmaceuticals International, Inc. (the “Company”) is a multinational, specialty pharmaceutical and medical device company that develops, manufactures, and markets a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (“OTC”) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices), which are marketed directly or indirectly in over </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> countries. Effective August 9, 2013, the Company continued from the federal jurisdiction of Canada to the Province of British Columbia, meaning that the Company became a company registered under the laws of the Province of British Columbia as if it had been incorporated under the laws of the Province of British Columbia. As a result of this continuance, the legal domicile of the Company became the Province of British Columbia, the Canada Business Corporations Act ceased to apply to the Company and the Company became subject to the British Columbia Business Corporations Act.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 1, 2015, the Company acquired Salix Pharmaceuticals, Ltd. (“Salix”), pursuant to an Agreement and Plan of Merger dated February 20, 2015, as amended on March 16, 2015 (the “Salix Merger Agreement”), with Salix surviving as a wholly owned subsidiary of Valeant Pharmaceuticals International (“Valeant”), a subsidiary of the Company (the “Salix Acquisition”). </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For further information regarding the Salix Acquisition, including the related financing, see Note 4 and Note 13.</font></div></div>
CY2015	us-gaap	Revenue Recognition Sales Of Goods RevenueRecognitionSalesOfGoods	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Sales </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For products sold directly to wholesalers and retailers, the Company recognizes product sales revenue when persuasive evidence of an arrangement exists, delivery has occurred, collectability is reasonably assured, and the price to the buyer is fixed or determinable, the timing of which is based on the specific contractual terms with each customer. Delivery occurs when title has transferred to the customer, and the customer has assumed the risks and rewards of ownership. As such, the Company generally recognizes revenue on a sell-in basis (i.e., record revenue upon delivery); however, based upon specific terms and circumstances, the Company has determined that, for certain arrangements with third parties, revenue should be recognized on a sell-through basis (i.e., record revenue when products are dispensed to patients). Refer to Note 2 for information regarding the arrangement with Philidor. With respect to the recent launch of Addyi® in the U.S. in the fourth quarter of 2015, the Company has determined that it does not have the ability to reasonably estimate returns due to a lack of historical returns data for this product or similar products. Therefore, the Company is recording revenue for Addyi® on a sell-through basis until it determines that returns can be reasonably estimated. In evaluating the proper revenue recognition for sales transactions, the Company considers all relevant factors, including additional discounts or extended payment terms which the Company grants to certain customers, often near the end of fiscal quarterly periods.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from product sales is recognized net of provisions for estimated cash discounts, allowances, returns, rebates, chargebacks and distribution fees paid to certain of the Company’s wholesale customers. The Company establishes these provisions concurrently with the recognition of product sales revenue.  Price appreciation credits are generated when the Company increases a product’s wholesaler acquisition cost (“WAC”) under our contracts with certain wholesalers. Under such contracts, the Company is entitled to credits from such wholesalers for the impact of that WAC increase on inventory currently on hand at the wholesalers. Such credits, which can be significant, are used to offset against the total distribution service fees the Company pays on all of its products to each wholesaler. Net revenue on these credits is recognized on the date that the wholesaler is notified of the price increase. The Company offers cash discounts for prompt payment and allowances for volume purchases to customers. Provisions for cash discounts and allowances are estimated based on contractual sales terms with customers, an analysis of unpaid invoices, and historical payment experience. The Company generally allows customers to return product within a specified period of time before and after its expiration date, excluding the Company’s European businesses which generally do not carry a right of return. Provisions for returns are estimated based on historical sales and return levels, taking into account additional available information such as historical return and exchange levels, external data with respect to inventory levels in the wholesale distribution channel, external data with respect to prescription demand for the Company’s products, remaining shelf lives of the Company’s products at the date of sale and estimated returns liability to be processed by year of sale based on analysis of lot information related to actual historical returns. The Company reviews its methodology and adequacy of the provision for returns on a quarterly basis, adjusting for changes in assumptions, historical results and business practices, as necessary. The Company is subject to rebates on sales made under governmental and managed-care programs in the U.S., and chargebacks on sales made to government agencies, group purchasing organizations and other indirect customers. Provisions for rebates and chargebacks are estimated based on historical utilization levels, relevant statutes with respect to governmental pricing programs and contractual sales terms with managed-care providers and group purchasing organizations. Changes in the level of utilization of the Company’s products through private or public benefit plans and group purchasing organizations will impact the amount of rebates and chargebacks that the Company is obligated to pay.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is party to product manufacturing and supply agreements with a number of commercialization counterparties in the U.S. Under the terms of these agreements, the Company’s supply prices for its products are determined after taking into consideration estimates for future returns, rebates, and chargebacks provided by each counterparty. The Company makes adjustments as needed to state these estimates on a basis consistent with this policy and its methodology for estimating returns, rebates and chargebacks related to its own direct product sales.</font></div></div>
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing the Company’s consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include: provisions for product returns, rebates, chargebacks, discounts and allowances, and distribution fees paid to certain wholesalers; useful lives of amortizable intangible assets and property, plant and equipment; expected future cash flows used in evaluating intangible assets for impairment; reporting unit fair values in testing goodwill for impairment; provisions for loss contingencies; provisions for income taxes, uncertain tax positions and realizability of deferred tax assets; and the allocation of the purchase price for acquired assets and businesses, including the fair value of contingent consideration. Under certain product manufacturing and supply agreements, management relies on estimates for future returns, rebates and chargebacks made by the Company’s commercialization counterparties. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s consolidated financial statements could be materially impacted.</font></div></div>

Files In Submission

Name	View Source	Status
0000885590-16-000101-index-headers.html	Edgar Link	pending
0000885590-16-000101-index.html	Edgar Link	pending
0000885590-16-000101.txt	Edgar Link	pending
0000885590-16-000101-xbrl.zip	Edgar Link	pending
a2015performancegraph.jpg	Edgar Link	pending
d157858dex1026.htm	Edgar Link	pending
d157858dex1027.htm	Edgar Link	pending
d157858dex1028.htm	Edgar Link	pending
d157858dex105.htm	Edgar Link	pending
exhibit211.htm	Edgar Link	pending
exhibit231.htm	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
exhibit322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g157858g73w46.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
valeant2015form10-k.htm	Edgar Link	pending
vrx-20151231.xml	Edgar Link	completed
vrx-20151231.xsd	Edgar Link	pending
vrx-20151231_cal.xml	Edgar Link	unprocessable
vrx-20151231_def.xml	Edgar Link	unprocessable
vrx-20151231_lab.xml	Edgar Link	unprocessable
vrx-20151231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BHC
Bausch Health Companies Inc. Stock $bhc

2015 Q4 Form 10-K Financial Statement

#000088559016000101 Filed on April 29, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC Bausch Health Companies Inc. Stock $bhc

2015 Q4 Form 10-K Financial Statement

#000088559016000101 Filed on April 29, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC
Bausch Health Companies Inc. Stock $bhc